A 92-person randomized controlled trial found that topical Pistacia atlantica (Baneh) fruit oil reduced knee osteoarthritis pain and improved activity levels slightly more than diclofenac over 4 weeks, with gains persisting 4 weeks after stopping treatment. The absolute difference was meaningful but modest, and the study's small size and short duration limit how much weight this carries.
Knee osteoarthritis affects millions of older adults and typically involves progressive cartilage breakdown that generates pain and stiffness. Current treatment options range from topical NSAIDs to systemic medications, with varying tolerability profiles. This trial investigated whether Baneh fruit oil, used traditionally in Iranian folk medicine for joint pain, could perform comparably to or better than a standard topical anti-inflammatory.
Researchers enrolled 92 patients with primary knee osteoarthritis and randomly assigned them to apply either Baneh ointment or topical diclofenac to their knee three times daily for four weeks. Both groups completed validated outcome measures: the Knee Injury and Osteoarthritis Outcome Score (KOOS), which captures pain, function, and quality of life across multiple domains, and the Visual Analog Scale (VAS) for pain intensity. Measurements were taken at baseline, week 4, and week 8 (four weeks after stopping treatment).
The headline finding: both groups improved significantly over the first four weeks, but the Baneh group showed greater gains. Pain reduction on the VAS and KOOS pain subscale favored Baneh (P = 0.001 and P < 0.001, respectively). Activity levels and quality of life also improved more in the Baneh group (P = 0.001 and P = 0.009). Notably, these differences persisted when participants were reassessed four weeks after stopping treatment. The Baneh group maintained better pain control and activity scores at week 8 compared to diclofenac (P values ranging from 0.018 to 0.028). Adverse events were minimal: only one temporary itching case was reported.
The study design included intention-to-treat analysis, which is appropriate for reducing bias from dropout. However, several limitations merit mention. The sample size of 92 is modest for detecting meaningful clinical differences. The trial lasted only four weeks of active treatment, offering no data on durability beyond two months. The mechanism by which Baneh oil might exert its effects remains unspecified—the abstract notes that traditional use focuses on analgesic properties, but the active constituents and their anti-inflammatory or pain-modulating pathways are not detailed here.
This trial provides preliminary evidence that Baneh fruit oil warrants further investigation for knee osteoarthritis symptom management. The advantage over diclofenac is real but not dramatic: both treatments reduced pain substantially, and Baneh's edge may reflect either genuine biological activity or contextual factors (placebo, expectation, application technique) that the double-blind design was meant to control for but cannot fully eliminate with small sample sizes.
If you have mild to moderate knee osteoarthritis and are exploring topical options, this does not yet constitute strong evidence to switch from proven treatments. Topical NSAIDs like diclofenac have decades of safety and efficacy data. However, if you have NSAID sensitivity or prefer plant-derived approaches and can access Baneh fruit oil, the safety profile here appears favorable enough to warrant a trial under guidance from a healthcare provider.
The persistence of benefit four weeks after stopping treatment is intriguing but speculative at this stage. It could suggest a slower-acting mechanism than NSAIDs, or simply regression to different baseline pain levels. Larger, longer-duration trials with mechanistic investigation would be needed to clarify.
General approaches to osteoarthritis symptom management that have stronger evidence support include resistance training to maintain periarticular muscle strength, post-meal walks for joint mobility without high impact, and maintaining sleep duration to support tissue repair and pain processing.
| Parameter | Details |
|---|---|
| Design | Double-blind randomized controlled trial |
| Population | Adults with primary knee osteoarthritis (n=92) |
| Interventions | Topical Baneh fruit oil vs topical diclofenac, 3x daily x 4 weeks |
| Primary Outcomes | KOOS (pain, activity, quality of life subscales); VAS pain scale |
| Assessment Points | Baseline, week 4 (end of treatment), week 8 (4 weeks post-treatment) |
| Key Finding | Baneh group showed greater pain reduction and activity improvement at weeks 4 and 8 |
| Adverse Events | One case of temporary itching (Baneh group, implied) |
| Funding | Not specified in abstract |
Parestani, P., Ansari, H., Ansari, H., et al. (2024). The effects of Pistacia atlantica Desf. Fruit oil on primary knee osteoarthritis: A randomized controlled clinical trial. Journal of Ethnopharmacology.
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.